| abstract |
The invention relates to a process for the preparation of 1,3-Dipherioxypropan-2 ~ on ~ derivatives and their therapeutically acceptable salts, which in medicaments optionally together with pharmaceutically acceptable diluents or carriers, in particular in a single dose of 10 to 500 mg of active ingredient The effectiveness of the new substances is based on their strong hypolpidemic effect. |